I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 香港序時辰醫藥科技有限公司 | Official English Name | HK XUSHICHEN PHARMACEUTICAL TECHNOLOGY LIMITED |
|---|---|---|---|
| Company Reg No. (CRN) | UBI Regime (8-Digit BRN Sole ID) | Business Reg No. (BRN / UBI) | 81532501 HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN |
| Incorporation Date | 2026-11-05 | Company Category | Private company limited by shares |
| Current Legal Status | Live | Statutory Filing Cycle | 2027-11-05(Under 1 Year · Exempt) |
| Registered Office Address | ROOM D06, 7/F, GOOD HOPE BUILDING, 612-618 NATHAN ROAD, MONG KOK, KOWLOON, HONG KONGGood Hope Building · Mong Kok · 357 Co-Located Entities → | ||
|---|---|---|---|
| Significant Controllers (SCR) | Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report. | ||
II. Companies Registry Document Retrieval(Form NNC1 & ND2A Filings)
| Document Name | Action |
|---|---|
NNC1 Incorporation Form (Company Limited by Shares) (English)Founding Shareholders & Directors | |
CI Certificate of Incorporation (CI) | |
A&A Articles of Association (A&A) (English) |
III. Commercial Due Diligence & Regulatory Risk Screening
IV. Similar Trade Names & Industry Directory
BRN: 20477829
CHINA PHARMACEUTICAL GROUP (HK) COMPANY LIMITED
中國國藥集團(香港)有限公司
BRN: 76515568
China Pharmaceutical Health Asset Management Co., Limited
中國醫藥健康資產管理有限公司
BRN: 77935806
CHINA PHARMACEUTICAL DEVELOPMENT CO., LIMITED
中國制藥發展股份有限公司
BRN: 81031351
Nowell International Management Consulting Limited
諾威國際管理諮詢有限公司
BRN: 81352090
KEIGO ADVISORY LIMITED
企高諮詢有限公司
BRN: 75012179
China Pharmaceutical Industry Holding Co., Limited
中國藥材實業控股有限公司